It is about preserving strength, movement quality, and long-term performance while body composition changes
One placebo-controlled trial, called ATTAIN-MAINTAIN, followed adults who had previously completed the SURMOUNT-5 obesity trial, a randomized controlled study evaluating whether tirzepatide, the active ingredient in Zepbound, led to greater body weight reduction versus semaglutide in adults with obesity
There is limited evidence suggesting it may modestly raise GLP-1 levels, though findings are inconsistent and based on small trials
Protein also helps stabilize blood sugar levels
GLP-1 receptor agonists have emerged as a major advancement, offering clinically meaningful and sustained weight loss alongside improvements in glycemic control and cardiovascular outcomes
Compounders offering such blended products tend to claim that these extra ingredients, which are commonly used as nutritional supplements, can prevent muscle loss, improve sleep quality, or even improve weight loss results